LexisNexis® Legal News Podcast for September 2, 2010

Allergan will pay $600 million for off-label marketing of Botox, and AIG directors and officers agree to settle a derivative lawsuit for $90 million. Hear these and other stories from LexisNexis® Mealey’s Publications. Copyright© 2010 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys or www.lexisnexis.com/community.

No related posts.

FREE Case Review

Defective DrugsAdverse reactions to medications on the market.

Personal InjuryPersonal injuries resulting from negligence may lead to significant medical expenses.

Toxic ExposureDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

DiseasesDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

Financial FraudsUnethical actions by large corporations may cause financial hardship.

Medical MalpracticeMedical errors or negligent health care resulting in injury or death.

LexisNexis® Legal News Podcast for September 2, 2010

FREE Case Review

Trending Topics